Condition
Kidney Ischemia
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07053462Phase 1Recruiting
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
NCT05747053Terminated
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
NCT04933604Completed
LPN in Patients With High-complex Renal Tumors
NCT04693962Unknown
FGF23 as a Marker of Acute Kidney Injury
NCT04213157Completed
Laparoscopic Partial Nephrectomy for cT1 Tumors
Showing all 5 trials